Dr. Hongying Yang 杨宏英
Chief Physician
Department of Gynecology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, chemotherapy, radiotherapy, and endocrine treatment for benign and malignant gynecologic tumors. Colposcopy and cervical LEEP procedures.
Dr. Yang holds a master’s degree and is Deputy Director of the Department. Graduated from Kunming Medical University in 1988, with one year of advanced training at the Cancer Hospital of the Chinese Academy of Sciences. Oversees departmental teaching. Authored over 10 papers, co-edited two academic books, completed one research project, and leads two ongoing projects.
Name order: in Chinese the family name comes first (Yang Hongying). Papers usually list the name as Hongying Yang or Yang H.
Selected publications
49 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2026 (first author): Assessment of shear wave elastography for evaluating neoadjuvant chemotherapy efficacy in breast cancer: correlation of stiffness changes with pathological response. PubMed 43005094
- Recent Pat Anticancer Drug Discov, 2026 (senior author): Uncovering the Underlying Mechanism of Clotrimazole against Ovarian Cancer by Transcriptomics and Experimental Investigations. PubMed 42478651
- Cell Immunol, 2026 (senior author): Exosomes derived from ovarian cancer promote the progression of ovarian cancer through macrophage M2 polarization mediated by the THBS1/TGFBI signaling axis. PubMed 41275570
- Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2025 (senior author): Undifferentiated Uterine Sarcoma With SMARCA4 Gene Deletion: Report of Two Cases and Literature Review. PubMed 41503660
- Eur J Cancer Prev, 2025 (senior author): Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from Yunnan Province in southwest China. PubMed 39513675
- Contemp Oncol (Pozn), 2025 (senior author): Lactobacillus brevis YNH inhibits proliferation of HeLa cells and promotes their apoptosis by modulating the PI3K/AKT pathway. PubMed 40330442
- J Oncol, 2023 (senior author): Retinoblastoma-Binding Protein 5 Regulates H3K4 Methylation Modification to Inhibit the Proliferation of Melanoma Cells by Inactivating the Wnt/β-Catenin and Epithelial-Mesenchymal Transition Pathways. PubMed 36866240
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion